Company intelligence / Profile preview
Beijing Kanghong Biopharmaceutical
Beijing, Beijing, Chinaen.cnkh.com ↗
- Ownership
- Private
- Employees
- ~4462
- Development stage
- Phase 1
01
Overview
Beijing Kanghong Biopharmaceutical is an active Chinese biotech/pharma company focused on developing innovative biological drugs including monoclonal antibodies and gene therapies. It operates commercial-scale GMP manufacturing facilities in Beijing designed to meet NMPA, EMA & FDA standards. The company has at least two known clinical-stage programs targeting cancer and autoimmune indications. It is a subsidiary of Chengdu Kanghong Pharmaceutical Group—a major publicly traded pharmaceutical group with global operations.
- Therapeutic areas
- OncologyDermatology
- Modalities
- Monoclonal antibodiesBiological productsGene therapy
- Industry
- Biotech
02
Drug pipeline
1 assetBeyond the preview
Go deeper on Beijing Kanghong Biopharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing Kanghong Biopharmaceutical.